Functional HIV Cure: The Next Frontier in HIV Treatment
"Discover the latest research and strategies to achieve long-term HIV remission without medication."
For decades, antiretroviral therapy (ART) has been the cornerstone of HIV treatment, effectively suppressing the virus and allowing individuals to live long and healthy lives. However, ART is not a cure. It requires lifelong adherence and can come with significant side effects and costs. That’s why researchers are now exploring a variety of innovative interventions aimed at achieving what’s known as a “functional cure” – a state of sustained remission where the virus is controlled without the need for ongoing medication.
A functional cure represents a paradigm shift in HIV treatment, offering the promise of ART-free periods, reduced side effects, and decreased costs. But what exactly does it take to achieve this ambitious goal? A groundbreaking study published in Nature Reviews Immunology delves into the challenges and potential strategies for inducing long-term HIV remission. By using mathematical modeling, the researchers provide insights into the scale of the challenge and the efficacy required for different approaches.
This article unpacks the key findings of the study, exploring the most promising avenues for achieving a functional HIV cure. We will examine the strategies being explored, the hurdles that need to be overcome, and the exciting possibilities that lie on the horizon. Whether you're a healthcare professional, a person living with HIV, or simply interested in the future of medicine, this is your guide to understanding the next frontier in HIV treatment.
Current HIV Care Progress
The CDC reported that, in 2024, 83% of people newly diagnosed with HIV in the United States were linked to care within one month, a rate relatively similar to 2023. The agency described this as a slight improvement in HIV care and treatment outcomes while emphasizing continued need for expanded testing, prevention, and treatment. The National HIV/AIDS Strategy and the Ending the HIV Epidemic in the U.S. initiative aim to reduce disease, HIV-related disparities, and health inequities.
What Does It Take to Achieve a Functional Cure?
The study highlights that achieving a functional HIV cure is not a simple task. The virus has a remarkable ability to hide within the body, forming a “latent reservoir” of infected cells that can reactivate and cause the virus to rebound if ART is stopped. Therefore, any successful intervention must address this latent reservoir, either by eliminating it, shrinking it, or controlling its reactivation.
- Reducing the Latent Reservoir: This approach aims to eliminate or shrink the pool of latently infected cells. Strategies include:
- Small-molecule stimulation of latently infected cells to make them visible to the immune system.
- Targeting and destroying infected cell subsets.
- Improving Immune Responses: Enhancing the body's natural ability to control the virus. Strategies include:
- Active immunotherapy (vaccination) to boost the immune system.
- Passive immunotherapy (infusion of antibodies) to directly target the virus or infected cells.
- Gene Therapy: Modifying cells to make them resistant to HIV infection or to directly target the latent provirus. Strategies include:
- Using CRISPR-Cas9 technology to cleave and inactivate HIV proviral DNA.
Research Directions
A recent review describes HIV cure research as advancing through gene therapy, latency-reversing agents, immunotherapy, and stem cell transplants. These approaches are being studied toward either a sterilizing cure or a functional cure, in which HIV is not necessarily eliminated but is controlled. Another review identifies elite controllers and post-treatment controllers as important models for understanding the immunological, genetic, and virological mechanisms of HIV suppression.
Why a Cure Remains Unavailable
NIAID states that there is currently no cure for HIV. At the same time, advances in treatment have made it possible for people with HIV to live long and healthy lives. This distinction underscores that effective treatment has improved HIV outcomes without yet producing a generally available cure.
Sterilizing and Functional Cure
HIV cure research commonly distinguishes between a sterilizing cure and a functional cure. A sterilizing cure seeks to completely eradicate HIV from the body, whereas a functional cure leaves the virus present but enables long-term viral suppression without antiretroviral therapy. One analysis notes that these binary concepts have organized the field for more than a decade while also examining how the expression functional cure is used in research and community discussions.
The Path Forward: Combining Strategies and Overcoming Challenges
The study emphasizes that a combination of strategies will likely be needed to achieve a functional HIV cure. By combining approaches that target different aspects of the virus and the immune system, researchers hope to achieve the level of efficacy needed for long-term remission. This might involve combining therapies that reduce the latent reservoir with those that boost immune responses or make cells resistant to infection. While the challenges are significant, the potential benefits of a functional HIV cure are enormous. Continued research and innovation are essential to translate these promising strategies into reality and bring hope to millions of people living with HIV.
Predicting Post-Treatment Remission
A small HIV reservoir is necessary but insufficient for post-treatment remission to qualify as a functional HIV cure. The editorial therefore argues that complementary biomarkers are needed to accurately predict whether remission will occur after treatment. This limitation shows why reservoir size alone cannot determine the likelihood of sustained HIV control.
A Reported Elite-Controller Case
A Lancet HIV report described a case of functional cure in an exceptional elite controller, a 48-year-old Indian woman living in Spain who had been diagnosed with HIV in 2002. The report was identified as the third reported case of functional cure in an elite controller. Such cases are clinically important because they provide human examples for investigating characteristics associated with long-term HIV control.